GI
ADMA icon

GAMMA Investing’s ADMA Biologics ADMA Stock Holding History

GAMMA Investing’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.3K Sell
2,903
-355
-11% -$3.24K ﹤0.01% 2738
2026
Q1 		$29.4K Buy
3,258
+156
+5% +$2.46K ﹤0.01% 2510
2025
Q4 		$56.6K Sell
3,102
-497
-14% -$8.38K ﹤0.01% 1989
2025
Q3 		$52.8K Sell
3,599
-4,014
-53% -$68.8K ﹤0.01% 1953
2025
Q2 		$139K Buy
7,613
+1,024
+16% +$20.9K 0.01% 1182
2025
Q1 		$131K Buy
6,589
+4,715
+252% +$81.5K 0.01% 1045
2024
Q4 		$32.1K Buy
1,874
+967
+107% +$18.2K ﹤0.01% 1998
2024
Q3 		$18.1K Buy
907
+413
+84% +$6.42K ﹤0.01% 2163
2024
Q2 		$5.52K Hold
494
– – ﹤0.01% 2536
2024
Q1 		$3.26K Buy
494
+345
+232% +$1.89K ﹤0.01% 2575
2023
Q4 		$773 Buy
+149
New +$551 ﹤0.01% 2866

Other funds holding ADMA

AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
MCM
Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

GAMMA Investing's ADMA Position: Q2 2026 in Review

GAMMA Investing reduced its ADMA Biologics (ADMA) stake by 11% in Q2 2026, selling an estimated $3.24K and leaving 2,903 shares worth $24.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2738.

GAMMA Investing first reported a position in ADMA in Q4 2023 and has held it in 11 quarters since. The position peaked at $139K in Q2 2025. 62 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • GAMMA Investing held 2,903 shares of ADMA Biologics worth $24.3K as of Q2 2026.
  • GAMMA Investing sold 355 ADMA Biologics shares in Q2 2026, an estimated $3.24K.
  • ADMA Biologics made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2738 holding.
  • GAMMA Investing first reported a position in ADMA Biologics in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's ADMA Biologics position peaked at $139K in Q2 2025.
  • 62 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.